COMMUNIQUÉS West-GlobeNewswire

Inspire’s Health Profiles Identifies the Insights of Patients to Unlock Research Gaps
13/12/2018
Company invites new global academic collaborations to accelerate clinical research ARLINGTON, Va., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Inspire, the leading healthcare social network for patients and caregivers, is [...]
Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California
13/12/2018
New facility expected to create more than 100 new jobs, supporting extensive gene therapy pipeline Enhances Orchard’s capacity to develop and deliver lentiviral vector and gene-corrected hematopoetic stem cells for wide [...]
HEXO Corp reports $6.7 million in gross revenue for the first quarter of new fiscal year
13/12/2018
Sales of $5.2 million for adult-use cannabis during the first two weeks of legalization in Canada Creation of Truss, a partnership with Molson Coors Canada in support of the Company’s objective to partner with Fortune [...]
HEXO Corp déclare des revenus bruts de 6,7 millions de dollars pour le premier trimestre du nouvel exercice
13/12/2018
Ventes de 5,2 millions de dollars de cannabis destiné au marché adulte au cours des deux premières semaines suivant la légalisation au Canada Création de Truss, un partenariat avec Molson Coors Canada à l’appui de l’ [...]
Altimmune Announces Clinical Program Updates and Plans for Pipeline Expansion
13/12/2018
GAITHERSBURG, Md., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced updates to its clinical programs and plans to further expand its pipeline [...]
ProQR Announces Strategic Changes to the Management Team and Key New Hires
13/12/2018
LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 13, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA [...]
Hi Fidelity Genetics Closes Series A Financing to Automate Plant Breeding
13/12/2018
Top Ag Financiers Invest in AI-Platform to Bring Predictive Data Science to Crop Breeding DURHAM, N.C., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Hi Fidelity Genetics (HFG), a computational crop breeding company, announced it [...]
Rhythm Pharmaceuticals Announces First Patient Enrolled in Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes
13/12/2018
Company to host KOL Symposium focused on Bardet-Biedl Syndrome in New York City; live webcast beginning at 8:30am ET BOSTON, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a [...]
Antares Pharma Announces the Appointment of Peter S. Greenleaf to Company’s Board of Directors
13/12/2018
EWING, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Peter S. Greenleaf to the Company’s Board of Directors. Mr. Greenleaf has over 20 years of [...]
NeoGenomics Appoints Dr. Lawrence M. Weiss as Chief Scientific Officer
13/12/2018
FT. MYERS, Fla., Dec. 13, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced the appointment of Lawrence M. Weiss, M.D. as Chief [...]
Bellicum Pharmaceuticals Appoints Atabak Mokari as Chief Financial Officer
13/12/2018
HOUSTON, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
Avinger Announces Successful Treatment of 500th Patient with Next-Generation Pantheris Device
13/12/2018
38% Year-over-Year Pantheris Revenue Growth in First Full Quarter of Launch REDWOOD CITY, Calif., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for [...]
AMAG Pharmaceuticals Enters Into Definitive Merger Agreement to Acquire Perosphere Pharmaceuticals
13/12/2018
Next Generation Anticoagulant Reversal Agent, Ciraparantag, Will Add Innovative Clinical Stage Asset to AMAG’s Hematology Portfolio Conference call scheduled for 8:00 a.m. ET today WALTHAM, Mass., Dec. 13, 2018 (GLOBE [...]
Les résultats de l’étude de phase 2 visant à traiter la dermatite atopique réalisée par XBiotech semblent indiquer un nouveau traitement pour la maladie dermatologique
13/12/2018
Le traitement par bermekimab réduit de manière rapide et significative la maladie. AUSTIN, Texas, 13 déc. 2018 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ : XBIT) a annoncé aujourd’hui la conclusion de l’étude ouverte [...]
Meetings Held With FDA Support Mesoblast’s Planned Regulatory Filing for Commercialization of Remestemcel-L in Acute GVHD
13/12/2018
NEW YORK and MELBOURNE, Australia, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that recent meetings held with the United States Food and Drug Administration (FDA) support [...]
Ossur Hf : Financial calendar 2019
13/12/2018
Announcement no. 71/2018 13 December 2018 Össur's financial calendar 2019 Interim Report Q4 2018 and Annual Report for 2018 5 February 2019 Annual General Meeting 7 March 2019 Interim Report Q1 2019 30 April 2019 [...]
IMV Inc. Presents Updated Positive Data From Phase 1b/2 Combination Clinical Trial in Advanced Ovarian Cancer at 2018 ESMO Immuno-Oncology Congress
13/12/2018
73% of tumor regressions and 80% of clinical responses were observed in a subpopulation defined by a clinical biomarker based on Baseline Tumor Burden All durable clinical responses continued beyond the one year of [...]
Curetis Sharpens Focus on Near-Term Strategic Value Drivers
13/12/2018
Business focus on U.S. commercialization, strategic partnering, Ares Genetics and asset monetization Reduction of net cash consumption by up to 50% (YoY) expected Amsterdam, the Netherlands, Holzgerlingen, Germany, and [...]
PledPharma presents results from study on drug candidate Aladote® for paracetamol poisoning at a global toxicology conference
13/12/2018
Stockholm, December 13, 2018. PledPharma AB (publ) announces that the company's Aladote ® Phase Ib/IIa study results has been accepted for a poster presentation during the “58th Annual Meeting of the Society of [...]

Pages